home / stock / afmd / afmd short
Short Information | Affimed N.V. (NASDAQ:AFMD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 469,168 |
Total Actual Volume | 2,162,664 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 23,458 |
Average Short Percentage | 20.53% |
Is there a AFMD Short Squeeze or Breakout about to happen?
See the AFMD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $5.36 | $4.88 | $5.435 | $4.865 | 65,492 | 15,465 | 23.61% |
04-23-2024 | $5.08 | $5.35 | $5.46 | $5.08 | 21,998 | 5,554 | 25.25% |
04-22-2024 | $5.07 | $5 | $5.25 | $4.72 | 95,885 | 17,011 | 17.74% |
04-19-2024 | $5.13 | $5.15 | $5.21 | $5 | 63,710 | 9,012 | 14.15% |
04-18-2024 | $5.29 | $5.07 | $5.29 | $5.07 | 89,527 | 20,561 | 22.97% |
04-17-2024 | $5.28 | $5.23 | $5.37 | $5.19 | 32,756 | 5,264 | 16.07% |
04-16-2024 | $5.46 | $5.37 | $5.4991 | $5.17 | 40,155 | 12,890 | 32.1% |
04-15-2024 | $5.76 | $5.49 | $5.9199 | $5.42 | 58,463 | 9,003 | 15.4% |
04-12-2024 | $5.89 | $5.75 | $6 | $5.63 | 95,109 | 15,856 | 16.67% |
04-11-2024 | $5.89 | $5.91 | $5.965 | $5.62 | 115,344 | 28,212 | 24.46% |
04-10-2024 | $6.02 | $5.83 | $6.1 | $5.72 | 71,664 | 18,738 | 26.15% |
04-09-2024 | $6.32 | $6.1 | $6.39 | $6.04 | 86,453 | 17,985 | 20.8% |
04-08-2024 | $6.49 | $6.33 | $6.51 | $6.2001 | 73,323 | 13,463 | 18.36% |
04-05-2024 | $6.52 | $6.48 | $6.52 | $6.2017 | 122,086 | 15,734 | 12.89% |
04-04-2024 | $6.64 | $6.55 | $6.88 | $6.3 | 143,344 | 26,581 | 18.54% |
04-03-2024 | $6.4 | $6.66 | $7.24 | $6.39 | 252,815 | 57,652 | 22.8% |
04-02-2024 | $6.05 | $6.44 | $7.07 | $5.73 | 324,260 | 88,692 | 27.35% |
04-01-2024 | $5.38 | $6.35 | $6.43 | $5.2098 | 228,287 | 68,708 | 30.1% |
03-28-2024 | $5.33 | $5.3 | $5.4302 | $5.11 | 80,919 | 10,820 | 13.37% |
03-27-2024 | $5.41 | $5.33 | $5.65 | $5.3 | 101,074 | 11,967 | 11.84% |
News, Short Squeeze, Breakout and More Instantly...
Affimed N.V. Company Name:
AFMD Stock Symbol:
NASDAQ Market:
The preliminary results from the phase 2 study investigating AFM24 in combination with the checkpoint inhibitor atezolizumab in patients with EGFR wild-type non-small cell lung cancer have been accepted for poster presentation MANNHEIM, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- Affimed N....
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer (NSCLC) EGFR -wildtype cohort: one complete response (CR), three partial responses (PR), and seven stable disease patients in the 15 heavily p...